T cells in the TME of advanced cancer showed increased expression of PD1, CTLA4, CD39, PD-L2, LAG3, TIGIT, Tim3 and decreased expression of CD73 (Fig. 6a, b and Supplementary Fig. 11a). The gene discussed is HAVCR2; the disease is cancer.